ALLHAT Study Brings Calls For Comparative Trials, Greater Focus On Costs
Executive Summary
The ALLHAT hypertension trial is bringing renewed calls for more comparative trials of pharmaceutical agents
You may also be interested in...
Pfizer, Novartis Learning The VALUE Of Comparative Research
A Novartis-sponsored study comparing Diovan to Pfizer's Norvasc highlights the risk firms take in conducting comparative research
Pfizer, Novartis Learning The VALUE Of Comparative Research
A Novartis-sponsored study comparing Diovan to Pfizer's Norvasc highlights the risk firms take in conducting comparative research
AHRQ Comparative Study Agenda Should Emphasize Lit Reviews – McClellan
The federal government's investment in comparative effectiveness research for drugs should emphasize literature reviews and other alternatives to clinical trials, Centers for Medicare & Medicaid Services Administrator Mark McClellan said